The payment, which is part of the initiated partnership with Synthos, follows the EUR 1.5 million received for the successful completion of the first phase of the butadiene programme in December 2012.
The payment, which is part of the initiated partnership with Synthos, follows the EUR 1.5 million received for the successful completion of the first phase of the butadiene programme in December 2012.